Peldacyn Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Clindamycin (cap: HCl; inj: phosphate)

Indications/Uses

Upper resp tract (eg, chronic or recurrent tonsillitis, pharyngitis, sinusitis, otitis media & scarlet fever) & lower resp tract (eg, bacterial bronchitis, pneumonia, empyema, lung abscess) infections; difficult to treat skin & soft tissue infections (eg, acne, furunculosis), cellulitis), impetigo, abscesses, wound infections, erysipelas, nail wall infections); bone & joint infections (eg, osteomyelitis & septic arthritis); gynaecological infections (eg, endometritis, tubo-ovarian abscess, salpingitis, infections of the cervical area & inflammatory diseases of the pelvic area in combination w/ antibiotic effective against gm -ve aerobic bacteria); intra-abdominal infections (eg, peritonitis & abdominal abscess in combination w/ antibiotic effective against gm -ve aerobic bacteria; dental infections (eg, periodontal abscess & periodontitis). As monotherapy for cervicitis caused by Chlamydia trachomatis.

Click to view Peldacyn detailed prescribing information

Dosage/Direction for Use

Cap Adult, elderly & adolescent >14 yr 600-1,800 mg/day in 3-4 equal divided doses. Childn & adolescent 8-25 mg/kg/day. Infections due to β-haemolytic strep Duration of treatment: At least 10 days. IM/IV Adult Serious infection 600-1,200 mg/day divided in 2-4 equal doses. More severe infection 1,200-2,700 mg/day divided in 2-4 equal doses. Infuse over at least 10-60 min. Childn >1 mth Serious infection 15-25 mg/kg/day in 3-4 equal doses. More severe infection 25-40 mg/kg/day in 3-4 equal doses. Neonate <1 mth 15-20 mg/kg/day in 3-4 equal doses.

Click to view Peldacyn detailed prescribing information

Overdosage

View Peldacyn overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Take w/ a full glass of water to avoid oesophageal irritation.

Contraindications

Hypersensitivity to clindamycin or lincomycin. Inj: Treatment of meningitis; nonbacterial upper resp or mild bacterial infections. Lactation.

Click to view Peldacyn detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Peldacyn detailed prescribing information

Special Precautions

Pregnancy. Should not be taken during lactation. Cap: Severe hypersensitivity reactions including severe skin reactions eg, drug reaction w/ eosinophilia & systemic symptoms, SJS, TEN & acute generalised exanthematous pustulosis. Patients w/ existing penicillin allergy. Consider diagnosis of Clostridium difficile-associated diarrhea in patients who present diarrhea subsequent to the administration of antibacterials. History of GI disease especially colitis. Not to be used in the treatment of meningitis. Overgrowth of non-susceptible organisms particularly yeasts. Renal & hepatic function tests should be performed in prolonged therapy. Inj: Do not inj IV undiluted as a bolus. Patients w/ history of colitis, renal or hepatic disease; dysphagia. Atopic individuals. Neonate, immature fetus. Elderly.

Click to view Peldacyn detailed prescribing information

Use In Pregnancy & Lactation

Click to view Peldacyn detailed prescribing information

Adverse Reactions

Cap: Pseudomembranous colitis; eosinophilia; diarrhea; maculopapular rash; abnormal LFT. Inj: Local & hypersensitivity reactions; GI, skin, hepatic, renal, musculoskeletal, hematopoietic & nervous system effects; shock.

Click to view Peldacyn detailed prescribing information

Drug Interactions

May enhance action of neuromuscular blocking agents. In vitro antagonism w/ erythromycin. May reduce clearance w/ CYP3A4 & CYP3A5 inhibitors. May increase clearance w/ CYP3A4 & CYP3A5 inducers. Cross-resistance w/ lincomycin. Increased PT/INR &/or bleeding w/ vit K antagonist (eg, warfarin, acenocoumarol & fluindione).

Click to view Peldacyn detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Peldacyn detailed prescribing information

Storage

View Peldacyn storage conditions for details to ensure optimal shelf-life.

Description

View Peldacyn description for details of the chemical structure and excipients (inactive components).

Action

View Peldacyn mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Antibiotics

ATC Classification

J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Peldacyn cap 300 mg

Packing/Price

30's (P1,020/box)

Form

Peldacyn soln for inj 150 mg/mL

Packing/Price

2 mL x 10 × 1's (P3,342/box, P334.2/ampoule);4 mL x 10 × 1's (P501.3/ampoule, P5,012.75/box)

Peldacyn

clindamycin

Manufacturer:

Natrapharm

Distributor:

Natrapharm